[Adapting the dose to the residual concentration of infliximab in cryptogenic inflammatory diseases of the intestines]
- PMID: 26058185
[Adapting the dose to the residual concentration of infliximab in cryptogenic inflammatory diseases of the intestines]
Comment on
-
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.Gastroenterology. 2015 Jun;148(7):1320-9.e3. doi: 10.1053/j.gastro.2015.02.031. Epub 2015 Feb 24. Gastroenterology. 2015. PMID: 25724455 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical